D-1821-2015 Class I Terminated
FDA drug recall D-1821-2015 was initiated by Pharmedium Services, LLC on Jan 28, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human… The recall status is terminated (terminated Jan 27, 2017). Affected quantity: 240 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 30, 2015
- Initiation Date
- Jan 28, 2015
- Termination Date
- Jan 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 240 bags
Product Description
PHENYLephrine HCl, 50 mg added to 250 mL 0.9% Sodium Chloride Injection USP (200 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX 77478, NDC# 61553-171-50
Reason for Recall
Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).
Distribution Pattern
Nationwide
Code Information
Lot #: 14310039S, Exp 11/06/14; 14318006S, Exp 11/17/14; 14321060S, Exp11/07/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1821-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026